{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:51:19Z","timestamp":1782953479479,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Hirosaki University Karoji Memorial Medical Research Fund."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12975-024-01308-y","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:09:30Z","timestamp":1732054170000},"page":"1285-1292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cilostazol Alleviates Delayed Cerebral Ischemia After Subarachnoid Hemorrhage by Attenuating Microcirculatory Dysfunction"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6490-527X","authenticated-orcid":false,"given":"Masato","family":"Naraoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohkuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"5","key":"1308_CR1","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1212\/WNL.50.5.1413","volume":"50","author":"SC Johnston","year":"1998","unstructured":"Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50(5):1413\u20138.","journal-title":"Neurology"},{"issue":"2","key":"1308_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ van Asch","year":"2010","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral hemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167\u201376.","journal-title":"Lancet Neurol"},{"key":"1308_CR3","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","volume":"39","author":"RL Macdonald","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015\u201321.","journal-title":"Stroke"},{"issue":"7","key":"1308_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","volume":"10","author":"RL Macdonald","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping: a randomized, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u201325.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1308_CR5","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.648980","volume":"43","author":"RL MacDonald","year":"2012","unstructured":"MacDonald RL, Higashida RT, Keller E, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463\u20139.","journal-title":"Stroke"},{"issue":"2","key":"1308_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1179\/174313209X393564","volume":"31","author":"RM Pluta","year":"2009","unstructured":"Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res. 2009;31(2):151\u20138.","journal-title":"Neurol Res"},{"issue":"3, Supplement 1","key":"1308_CR7","first-page":"S86","volume":"40","author":"J Cahill","year":"2009","unstructured":"Cahill J, Zhang JH. Subarachnoid hemorrhage: is it time for a new direction? Stroke. 2009;40(3, Supplement 1):S86\u20137.","journal-title":"Stroke"},{"issue":"7","key":"1308_CR8","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1161\/01.STR.31.7.1621","volume":"31","author":"H Ohkuma","year":"2000","unstructured":"Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2000;31(7):1621\u20137.","journal-title":"Stroke"},{"issue":"3","key":"1308_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/jcbfm.2011.154","volume":"32","author":"B Friedrich","year":"2012","unstructured":"Friedrich B, M\u00fcller F, Feiler S, Sch\u00f6ller K, Plesnila N. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in vivo microscopy study. J Cereb Blood Flow Metab. 2012;32(3):447\u201355.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"1308_CR10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s12975-011-0117-x","volume":"2","author":"SHY Chou","year":"2011","unstructured":"Chou SHY, Feske SK, Simmons SL, et al. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of the functional outcome following subarachnoid hemorrhage. Transl Stroke Res. 2011;2(4):600\u20137.","journal-title":"Transl Stroke Res"},{"issue":"4","key":"1308_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nm.2333","volume":"17","author":"JP Dreier","year":"2011","unstructured":"Dreier JP. The role of spreading depression, spreading depolarization, and spreading ischemia in neurological disease. Nat Med. 2011;17(4):439\u201347.","journal-title":"Nat Med"},{"issue":"12","key":"1308_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11883-017-0690-x","volume":"19","author":"JR Geraghty","year":"2017","unstructured":"Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and toward a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50.","journal-title":"Curr Atheroscler Rep"},{"issue":"10","key":"1308_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11910-019-0990-3","volume":"19","author":"V Rass","year":"2019","unstructured":"Rass V, Helbok R. Early brain injury after poor-grade subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2019;19(10):78.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"July","key":"1308_CR14","first-page":"1","volume":"14","author":"P Pan","year":"2020","unstructured":"Pan P, Xu L, Zhang H, et al. A review of the hematoma component clearance mechanism after subarachnoid hemorrhage. Front Neurosci. 2020;14(July):1\u201310.","journal-title":"Front Neurosci"},{"issue":"3","key":"1308_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1549-8719.2011.00155.x","volume":"19","author":"F Wang","year":"2012","unstructured":"Wang F, Hu Q, Chen CH, et al. The protective effect of Cerebralcare Granule\u00ae on brain edema, cerebral microcirculatory disturbance, and neuron injury in a focal cerebral ischemia rat model. Microcirculation. 2012;19(3):260\u201372.","journal-title":"Microcirculation"},{"issue":"7","key":"1308_CR16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/01.STR.22.7.854","volume":"22","author":"H Ohkuma","year":"1991","unstructured":"Ohkuma H, Suzuki S, Kimura M, Sobata E. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1991;22(7):854\u20139.","journal-title":"Stroke"},{"issue":"1","key":"1308_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00006123-199707000-00036","volume":"41","author":"H Ohkuma","year":"1997","unstructured":"Ohkuma H, Itoh K, Shibata S, Suzuki S. Morphological changes of intraparenchymal arterioles after experimental subarachnoid hemorrhage in dogs. Neurosurgery. 1997;41(1):230\u20136.","journal-title":"Neurosurgery"},{"issue":"1","key":"1308_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0271678X211045446","volume":"42","author":"M Naraoka","year":"2022","unstructured":"Naraoka M, Matsuda N, Shimamura N, Ohkuma H. Role of microcirculatory impairment in delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2022;42(1):186\u201396.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1\u20132","key":"1308_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000445509","volume":"42","author":"N Matsuda","year":"2016","unstructured":"Matsuda N, Naraoka M, Ohkuma H, et al. Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. Cerebrovasc Dis. 2016;42(1\u20132):97\u2013105.","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"1308_CR20","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/0271678X17724682","volume":"38","author":"M Naraoka","year":"2018","unstructured":"Naraoka M, Matsuda N, Shimamura N, et al. Long-acting statin for aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. J Cereb Blood Flow Metab. 2018;38(7):1190\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1308_CR21","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDII Vergouwen","year":"2010","unstructured":"Vergouwen MDII, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135.","journal-title":"Stroke"},{"issue":"12","key":"1308_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00234-009-0575-y","volume":"51","author":"JW Dankbaar","year":"2009","unstructured":"Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJH, Rinkel GJE. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51(12):813\u20139.","journal-title":"Neuroradiology"},{"key":"1308_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.wneu.2015.08.052","volume":"85","author":"T Inagawa","year":"2016","unstructured":"Inagawa T. Risk factors for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of the literature. World Neurosurg. 2016;85:56\u201376.","journal-title":"World Neurosurg"},{"issue":"3","key":"1308_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12975-012-0247-9","volume":"4","author":"M Naraoka","year":"2013","unstructured":"Naraoka M, Munakata A, Matsuda N, Shimamura N, Ohkuma H. Suppression of the Rho\/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit. Transl Stroke Res. 2013;4(3):368\u201374.","journal-title":"Transl Stroke Res"},{"issue":"3","key":"1308_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/STROKEAHA.120.032397","volume":"52","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen J, Toyota Y, Keep RF, Xi G, Hua Y. Ultra-early cerebral thrombosis formation after experimental subarachnoid hemorrhage detected on T2* magnetic resonance imaging. Stroke. 2021;52(3):1033\u201342.","journal-title":"Stroke"},{"key":"1308_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.brainres.2010.07.040","volume":"1354","author":"V Friedrich","year":"2010","unstructured":"Friedrich V, Flores R, Muller A, Sehba FA. Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage. Brain Res. 2010;1354:179\u201387.","journal-title":"Brain Res"},{"issue":"1","key":"1308_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.expneurol.2011.10.029","volume":"233","author":"JM Pisapia","year":"2012","unstructured":"Pisapia JM, Xu X, Kelly J, et al. Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated prourokinase and clazosentan. Exp Neurol. 2012;233(1):357\u201363.","journal-title":"Exp Neurol"},{"issue":"1","key":"1308_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/jcbfm.2010.76","volume":"31","author":"M Sabri","year":"2011","unstructured":"Sabri M, Ai J, Knight B, et al. Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2011;31(1):190\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1308_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuroscience.2012.08.002","volume":"224","author":"M Sabri","year":"2012","unstructured":"Sabri M, Ai J, Lakovic K, D\u2019abbondanza J, Ilodigwe D, Macdonald RL. Mechanisms of microthrombi formation after experimental subarachnoid hemorrhage. Neuroscience. 2012;224:26\u201337.","journal-title":"Neuroscience"},{"issue":"6","key":"1308_CR30","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/jth.12574","volume":"12","author":"MDI Vergouwen","year":"2014","unstructured":"Vergouwen MDI, Knaup VL, Roelofs JJTH, de Boer OJ, Meijers JCM. Effect of recombinant ADAMTS-13 on microthrombosis and brain injury after experimental subarachnoid hemorrhage. J Thromb Haemost. 2014;12(6):943\u20137.","journal-title":"J Thromb Haemost"},{"key":"1308_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/161702","volume":"2014","author":"L Andereggen","year":"2014","unstructured":"Andereggen L, Neuschmelting V, von Gunten M, Widmer HR, Fandino J, Marbacher S. Role of microclot formation in an acute subarachnoid hemorrhage model in the rabbit. Biomed Res Int. 2014;2014:1\u201310.","journal-title":"Biomed Res Int"},{"issue":"4","key":"1308_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s004010051097","volume":"98","author":"H Ohkuma","year":"1999","unstructured":"Ohkuma H, Suzuki S. Histological dissociation between the intra- and extraparenchymal portions of the perforating small arteries after experimental subarachnoid hemorrhage in dogs. Acta Neuropathol. 1999;98(4):374\u201382.","journal-title":"Acta Neuropathol"},{"issue":"Pt 1","key":"1308_CR33","doi-asserted-by":"publisher","first-page":"130756","DOI":"10.1016\/j.ijbiomac.2024.130756","volume":"265","author":"C Liu","year":"2024","unstructured":"Liu C, Wang L, Zhou Y, et al. Biogenic crocetin-crosslinked chitosan nanoparticles with high stability and drug loading for efficient radioprotection. Int J Biol Macromol. 2024;265(Pt 1):130756.","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"1308_CR34","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/jcbfm.2009.88","volume":"29","author":"MDI Vergouwen","year":"2009","unstructured":"Vergouwen MDI, Bakhtiari K, Van Geloven N, Vermeulen M, Roos YB, Meijers JCM. Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009;29(10):1734\u201341.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1308_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.9.JNS12492","volume":"118","author":"N Senbokuya","year":"2013","unstructured":"Senbokuya N, Kinouchi H, Kanemaru K, et al. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg. 2013;118(1):121\u201330.","journal-title":"J Neurosurg"},{"issue":"4","key":"1308_CR36","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","volume":"42","author":"MDI Vergouwen","year":"2011","unstructured":"Vergouwen MDI, Ilodigwe D, MacDonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcomes by vasospasm-dependent and -independent effects. Stroke. 2011;42(4):924\u20139.","journal-title":"Stroke"},{"issue":"11","key":"1308_CR37","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.027","volume":"27","author":"H Saber","year":"2018","unstructured":"Saber H, Desai A, Palla M, Mohamed W, Seraji-Bozorgzad N, Ibrahim M. Efficacy of cilostazol in the prevention of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a meta-analysis. J Stroke Cerebrovasc Dis. 2018;27(11):2979\u201385.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1308_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jocn.2021.12.025","volume":"99","author":"L Li","year":"2022","unstructured":"Li L, Fu X, Qiu H, Shi P. Effects of cilostazol treatment for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of 14 studies. J Clin Neurosci. 2022;99:190\u2013203.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1308_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3171\/2021.7.JNS211239","volume":"137","author":"MH Snyder","year":"2022","unstructured":"Snyder MH, Ironside N, Kumar JS, et al. Antiplatelet therapy and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2022;137(1):95\u2013107.","journal-title":"J Neurosurg"},{"issue":"2","key":"1308_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000518731","volume":"51","author":"J Liu","year":"2022","unstructured":"Liu J, He J, Chen X, et al. Cilostazol for aneurysmal subarachnoid hemorrhage: an updated systematic review and meta-analysis. Cerebrovasc Dis. 2022;51(2):138\u201348.","journal-title":"Cerebrovasc Dis"},{"key":"1308_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.wneu.2021.02.069","volume":"150","author":"S Bohara","year":"2021","unstructured":"Bohara S, Garg K, Singh Rajpal PM, Kasliwal M. Role of cilostazol in the prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review, meta-analysis, and trial sequential analysis. World Neurosurg. 2021;150:161\u201370.","journal-title":"World Neurosurg"},{"issue":"6","key":"1308_CR42","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3171\/2015.4.JNS15484","volume":"124","author":"M Fujimoto","year":"2015","unstructured":"Fujimoto M, Shiba M, Kawakita F, et al. Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice. J Neurosurg. 2015;124(6):1693\u2013702.","journal-title":"J Neurosurg"},{"key":"1308_CR43","doi-asserted-by":"publisher","first-page":"8346","DOI":"10.1007\/s12035-018-1006-z","volume":"55","author":"L Liu","year":"2018","unstructured":"Liu L, Fujimoto M, Nakano F, et al. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice. Mol Neurobiol. 2018;55:8346\u201354.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1308_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12975-018-0650-y","volume":"10","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Nakatsuka Y, Yasuda R, et al. Dose-dependent inhibitory effects of cilostazol on delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. Transl Stroke Res. 2018;10(4):381\u20138.","journal-title":"Transl Stroke Res"},{"issue":"2","key":"1308_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12028-021-01330-0","volume":"35","author":"A Kawano","year":"2021","unstructured":"Kawano A, Sugimoto K, Suzuki M, et al. Association between spreading depolarization and delayed cerebral ischemia after subarachnoid hemorrhage: post hoc analysis of a randomized trial of the effect of cilostazol on delayed cerebral ischemia. Neurocrit Care. 2021;35(2):91\u20139.","journal-title":"Neurocrit Care"},{"issue":"6","key":"1308_CR46","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25361","volume":"84","author":"K Sugimoto","year":"2018","unstructured":"Sugimoto K, Nomura S, Shirao S, et al. Cilostazol decreases the duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage. Ann Neurol. 2018;84(6):873\u201385.","journal-title":"Ann Neurol"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-024-01308-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-024-01308-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-024-01308-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:02:31Z","timestamp":1750910551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-024-01308-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1007\/s12975-024-01308-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4387291\/v1","asserted-by":"object"}]},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The protocol for these studies was assessed and approved by the Committee of Medical Ethics of the Hirosaki University Graduate School of Medicine. Both studies were registered with the University Hospital Information Network Clinical Trials Registry (UMIN, No. 000014402 and No. 000015977).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants or their legal representatives obtained written, informed consent before treatment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no potential conflicts of interest concerning this article\u2019s research, authorship, and\u00a0publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}